Thanks to its second nine-figure venture round this year, Bicara Therapeutics has just become one of 2023’s top five private fundraisers. Added to the sizeable series B round it closed in March, today’s $165m series C financing brings total venture cash raised by the group this year to $273m.
Bicara Scoops Up $165m And Heads To Pivotal Trials
The group’s second major venture round this year makes it one of the most successful fundraisers of 2023.
